CEFMENOXIME HCL
Cefmenoxime hydrochloride is a cephalosporin inhibiting cell wall synthesis with broad gramnegative activity. Side effects include rash, fever, and GI discomfort. Only GMP materials will be supplied, logistics all according to GDP.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of action
Cefmenoxime hydrochloride is a third-generation cephalosporin with high stability to -lactamases and strong activity against both gram-negative and gram-positive organisms. It targets PBPs and disrupts peptidoglycan crosslinking, leading to bactericidal cell-wall damage.
Benefits and advantages
Used in hospital-pathogen research, -lactamase-stability studies, gram-negative susceptibility testing, cephalosporin SAR analysis, and PK/PD investigations of advanced-generation cephalosporins.
Side effects and risks
Risks include hypersensitivity, GI disturbances, hepatic enzyme alteration and selection of resistant subpopulations. Handle with antimicrobial compound safety measures.
Only GMP materials will be supplied, logistics all according to GDP.
Datasheet
| Molecular Formula | C16H17N5O7S2Cl |
|---|---|
| Molecular Weight | 1059.6 g/mol |
| CAS Number | 75738-58-8 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| Synonym | Cefmenoxime hydrochloride; 75738-58-8; Cefmenoxime HCl; Cefmax; Cefmenoxime hemihydrochloride |
| IUPAC/Chemical Name | bis((6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid);hydrochloride |
| InChl Key | MPTNDTIREFCQLK-UNVJPQNDSA-N |
| InChl Code | InChI=1S/2C16H17N9O5S3.ClH/c2*1-24-16(20-22-23-24)33-4-6-3-31-13-9(12(27)25(13)10(6)14(28)29)19-11(26)8(21-30-2)7-5-32-15(17)18-7;/h2*5,9,13H,3-4H2,1-2H3,(H2,17,18)(H,19,26)(H,28,29);1H/b2*21-8-;/t2*9-,13-;/m11./s1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

